HoloMonitor technology shows versatility as important tool in nanotechnology research
Researchers at University of Pannonia in Hungary recently published a scientific study where HoloMonitor technology from Phase Holographic Imaging (PHI) is used to study cell growth on nanostructures. The study confirms that HoloMonitor technology has a unique potential to become an important tool for investigating cellular behavior on nanostructures under the influence of pharmaceuticals.
In 2014 Henrik Persson at the Department of Solid State Physics at Lund University published his doctoral thesis “Nanowires in Cell Biology”. A substantial part of the thesis is based on measurements obtained using PHI’s HoloMonitor technology.
“Recently the department in Lund ordered their second HoloMonitor unit for applications in nanotechnology. The independent study by the researchers at University of Pannonia confirms HoloMonitor’s unique ability to analyze cells growing on nanostructures,” says CEO Peter Egelberg.
“When the researcher at University of Pannonia purchased their HoloMonitor our motorized sample stage was not available. We can now offer a motorized stage that addresses the issues discussed in the article and are excited about this new market opportunity.”
Links
Article abstract: http://dx.doi.org/10.1117/1.JBO.20.6.067002
Doctoral thesis “Nanowires in Cell Biology”: http://www.lunduniversity.lu.se/lup/publication/4610289
For additional information, please contact:
Peter Egelberg, CEO
Tel: +46 703 19 42 74
E-mail: peter.egelberg@phiab.se
Web: www.phiab.se
Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.